Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Ashland Board appoints Scott A. Tozier as new director

Published 15/04/2024, 12:46
Updated 15/04/2024, 12:46

Tozier is strategic advisor to the CEO, and former executive vice president and chief financial officer of Albemarle (NYSE:ALB) Corporation

WILMINGTON, Del., April 15, 2024 (GLOBE NEWSWIRE) -- Effective today, Ashland Inc . (NYSE: NYSE:ASH) has announced the appointment of Scott A. Tozier, strategic advisor to the CEO and former executive vice president and chief financial officer of Albemarle Corporation to its Board of Directors. Tozier will serve on the Board's Audit Committee and Environmental, Health, Safety and Quality Committee, each also effective April 15, 2024. Prior to Albemarle, Tozier held several leadership positions at Honeywell International (NASDAQ:HON), Inc. and served on the Board of Directors for Garrett Motion (NASDAQ:GTX), Inc.

Tozier is an experienced global executive with strong industry leadership in financial management, mergers and acquisitions, sustainability, information technology, corporate procurement and logistics and shared services.

With the addition of Tozier, Ashland temporarily increases the size of the Board to 10 members until the next Annual Stockholders Meeting in January 2025.

I am delighted to welcome Scott as a new director to the Ashland Board, said Guillermo Novo, chair and chief executive officer, Ashland. As we continue to sustainably shape and grow our portfolio through executing, globalizing, innovating and acquiring, I am confident Scott will provide key perspectives for our team.

To learn more, visit investor.ashland.com

About  Ashland  
Ashland Inc. (NYSE: ASH) is a global additives and specialty ingredients company with a conscious and proactive mindset for environmental, social and governance (ESG). The company serves customers in a wide range of consumer and industrial markets, including architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care and pharmaceutical. Approximately 3,800 passionate, tenacious solvers “ from renowned scientists and research chemists to talented engineers and plant operators “ thrive on developing practical, innovative and elegant solutions to complex problems for customers in more than 100 countries. Visit  ashland.com  and ashland.com/ESG to learn more.  

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Trademark, Ashland or its subsidiaries, registered in various countries.

FOR FURTHER INFORMATION:

Investor Relations:Media Relations:
William WhitakerCarolmarie C. Brown
+1 (614) 790-2095+1 (302) 995-3158
wcwhitaker@ashland.comccbrown@ashland.com

Attachment

  • Ashland_announces_new_board_member_FNL_20240415

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.